Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

NCT01968213 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

564

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: Rucaparib
DRUG: Placebo

Sponsor

pharmaand GmbH

Collaborators

[object Object]
[object Object]